Outset Medical reports Q1 EPS ($1.03), consensus (79c)

Reports Q1 revenue $27.86M, consensus $28.9M. “We delivered a solid first quarter and continued to make meaningful progress on our path to profitability, driven by disciplined execution and another quarter of record gross margin performance,” said Leslie Trigg, Chair and Chief Executive Officer. “With utilization strong and service margins expanding, we remain focused on driving broader adoption of Tablo across care settings and confident in our full-year outlook.”